| 000 | 01006 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514132825.0 | ||
| 264 | 0 | _c19981101 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0032-5481 | ||
| 024 | 7 |
_a10.1080/00325481.1963.11692903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKIRKENDALL, W M | |
| 245 | 0 | 0 |
_aIndications for treatment and present-day drug therapy in essential hypertension. _h[electronic resource] |
| 260 |
_bPostgraduate medicine _cJun 1963 |
||
| 300 |
_a540-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDiet, Sodium-Restricted |
| 650 | 0 | 4 | _aDihydroxyphenylalanine |
| 650 | 0 | 4 | _aEssential Hypertension |
| 650 | 0 | 4 | _aGanglionic Blockers |
| 650 | 0 | 4 | _aGuanethidine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydralazine |
| 650 | 0 | 4 | _aHypertension |
| 650 | 0 | 4 | _aRauwolfia |
| 773 | 0 |
_tPostgraduate medicine _gvol. 33 _gp. 540-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00325481.1963.11692903 _zAvailable from publisher's website |
| 999 |
_c13796001 _d13796001 |
||